Clinical Trials Logo

Urinary Urge Incontinence clinical trials

View clinical trials related to Urinary Urge Incontinence.

Filter by:

NCT ID: NCT06222515 Completed - Clinical trials for Stress Urinary Incontinence

Bladder Diary for Female Storage LUTS

Start date: July 1, 2009
Phase:
Study type: Observational

Storage urinary symptoms are the most complained of lower urinary tract symptoms (LUTS) and need further classification. This original study aims to derive a novel classification algorism for female storage LUTS according to a 3-day bladder diary (BD). Further feasibility of the application was also evaluated.

NCT ID: NCT06217328 Recruiting - Clinical trials for Urinary Urge Incontinence

RESTORE: An RCT to Evaluate the Efficacy of the Revi System

Start date: February 24, 2024
Phase: N/A
Study type: Interventional

The Revi System is indicated for the treatment of patients with symptoms of urgency incontinence alone or in combination with urinary urgency.

NCT ID: NCT06161506 Recruiting - Clinical trials for Stress Urinary Incontinence

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

Start date: February 15, 2024
Phase: Phase 2
Study type: Interventional

Background: Men who are treated for prostate cancer often develop urinary leakage (incontinence). An experimental device that uses electrical impulses to stimulate pelvic floor muscles and surrounding tissues may help. Objective: To see if the Elidah device can reduce urinary incontinence after prostate treatment. Eligibility: Men aged 18 years and older who have had moderate urinary incontinence for at least 6 months after treatment for prostate cancer. Design: Participants will be in the study for about 9 weeks. They will be screened. They will have a physical exam with urine tests. The Elidah device consists of a Controller and a GelPad. The Controller sets the strength of electrical impulses. The GelPad is placed against the skin under the pelvis. Participants will be given an Elidah device and taught how to use it at home. They will use the device once a day for 20 minutes at a time; they will do this 5 days a week for 6 weeks. Participants will complete a daily log. They will record the strength of electrical impulses (0-35); the number of incontinence episodes; the type of incontinence episode; and the number of used pads. Participants will do a pad weight test. For 3 days before and 3 days after using the Elidah device, they will collect all of their used pads for each 24-hour period into a sealed plastic bag. They will also collect a second set of bags that contain dry versions of each product used. Participants will have clinic visits after using the device for 3 weeks and after finishing the 6 weeks of treatment. Participants will complete 15-minute questionnaires.

NCT ID: NCT06085846 Enrolling by invitation - Clinical trials for Urinary Incontinence

Real-World Registry - The Vivally® System

Start date: July 14, 2023
Phase:
Study type: Observational [Patient Registry]

This is a Real-World Registry Study to collect real-world dosing, utilization, demographic, quality of life, and data from the e-bladder diaries of patients utilizing the Vivally® System. Data points will be drawn from the Avation Medical HIPAA-compliant cloud database including but not limited to: Therapy compliance and stimulation metrics Diary entries provided by patients Various questionnaires Participants have the option to opt out of allowing their data to be part of any publication at any time.

NCT ID: NCT05685433 Recruiting - Overactive Bladder Clinical Trials

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

RECIPE
Start date: January 26, 2023
Phase: N/A
Study type: Interventional

A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).

NCT ID: NCT05543382 Active, not recruiting - Clinical trials for Overactive Bladder Syndrome

Cycling Study With the Axonics System

Start date: August 9, 2022
Phase:
Study type: Observational [Patient Registry]

A prospective, multi-center, study comparing continuous sacral neuromodulation (SNM) stimulation to daily cyclic stimulation of 2 hours "on" and 22 hours "off" using the Axonics System.

NCT ID: NCT05381116 Terminated - Overactive Bladder Clinical Trials

A Sham-Controlled Study to Evaluate the Safety and Efficacy of a Smart, Self-Adjusting, Surgery-Free, Wearable Bladder Neuromodulation System for Overactive Bladder

REDUCEOAB
Start date: April 14, 2022
Phase: N/A
Study type: Interventional

This is a prospective, multi-center, sham-controlled study comparing the safety and effectiveness of the self-adjusting, surgery-free, wearable Active System to a Sham System on adult Subjects diagnosed with OAB.

NCT ID: NCT05309993 Recruiting - Overactive Bladder Clinical Trials

INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder

INTENSE
Start date: June 30, 2022
Phase: N/A
Study type: Interventional

The objective of this research is to perform a non-masked, non-inferiority randomized controlled trial to assess the quality of life (QOL) of women with idiopathic overactive bladder (OAB) before and after treatment with percutaneous tibial nerve stimulation (PTNS) or transcutaneous electrical nerve stimulation (TENS) of tibial nerve. The target population is patients with OAB who previously failed first- and second-line treatments and desire non-surgical management.

NCT ID: NCT05308979 Active, not recruiting - Overactive Bladder Clinical Trials

Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial

Start date: May 1, 2022
Phase: Phase 4
Study type: Interventional

Patients with either overactive bladder (OAB) or urgency urinary incontinence (UUI) with be randomized (like a flip of a coin) to receive 100 units of bladder Botox® at either one injection site or ten injection sites. Efficacy and patient satisfaction will be measured by questionnaires.

NCT ID: NCT05064384 Completed - Fecal Incontinence Clinical Trials

Axonics SacRal NeuromodulaTIon System RegisTRY Study

ARTISTRY
Start date: November 30, 2020
Phase:
Study type: Observational [Patient Registry]

To assess the post-market clinical outcomes with use of the Axonics Sacral Neuromodulation System(s).